AI in pharma commercialisation is transforming patient and healthcare provider engagement, streamlining regulatory reviews, and developing hyper-informed treatment pricing models, despite current scaling challenges.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
